Page last updated: 2024-08-05 11:25:45

2-nitrophenols

A mononitrophenol that is 2-nitrophenol and its derivatives resulting from substitution of one or more of the hydrogens attached to the benzene ring by a non-nitro group.

ChEBI ID: 86421

Members (8)

MemberDefinitionRole
2-nitrophenolA member of the class of 2-nitrophenols that is phenol in which one of the hydrogens that is ortho to the hydroxy group has been replaced by a nitro group.2-nitrophenol
3-nitrotyrosineA nitrotyrosine comprising tyrosine having a nitro group at the 3-position on the phenyl ring.3-nitrotyrosine
4-amino-2-nitrophenol4-Amino-2-nitrophenol
4-hydroxy-3-nitrophenylacetyl-o-succinimide esterThe ester formed between N-hydroxysuccinimide and (4-hydroxy-3-nitrophenyl)acetic acid.1-((4-hydroxy-3-nitrophenyl)acetoxy)pyrrolidine-2,5-dione
entacaponeA monocarboxylic acid amide that is N,N-diethylprop-2-enamide in which the hydrogen at position 2 is substituted by a cyano group and the hydrogen at the 3E position is substituted by a 3,4-dihydroxy-5-nitrophenyl group.entacapone
nitrohydroxyiodophenylacetateA member of the class of phenylacetic acids that is phenylacetic acid in which the phenyl group is substituted by iodo, hydroxy and nitro groups at positions 3, 4 and 5 respectively.(4-hydroxy-3-iodo-5-nitrophenyl)acetic acid
roxarsoneAn organoarsonic acid where the organyl group is 4-hydroxy-3-nitrophenyl.roxarsone
tolcaponeBenzophenone substituted on one of the phenyl rings at C-3 and C-4 by hydroxy groups and at C-5 by a nitro group, and on the other phenyl ring by a methyl group at C-4. It is an inhibitor of catechol O-methyltransferase.tolcapone

Research

Studies (4,568)

TimeframeStudies, Drugs in This Class (%)All Drugs %
pre-1990125 (2.74)18.7374
1990's498 (10.90)18.2507
2000's2,132 (46.67)29.6817
2010's1,598 (34.98)24.3611
2020's215 (4.71)2.80

Study Types

Publication TypeStudies, Drugs in This Class (%)All Drugs (%)
Trials282 (5.79%)5.53%
Reviews262 (5.38%)6.00%
Case Studies49 (1.01%)4.05%
Observational4 (0.08%)0.25%
Other4,270 (87.73%)84.16%